Cancer drug discovery technologies get a £4.5m boost

Oct 5, 2020, 14:15 PM by User Not Found

Improving imaging technologies for cancer drug discovery with a £4.5 m Cancer Research UK Accelerator Award collaboration between Imperial College London, the Francis Crick Institute, the University of Edinburgh, the Institute of Cancer Research and the Instituto de Recerca Biomedica in Barcelona.

Imperial academics will lead a project to improve imaging technologies for cancer drug discovery, funded by CRUK and European partners.

The funding is part of the Cancer Research UK Accelerator Awards programme, which provides five years of funding for international projects.

The £4.5m project will be led by Professor Paul French from the Department of Physics at Imperial, with collaborators across the Faculties of Natural Sciences and Medicine, and partners in the Francis Crick Institute, the University of Edinburgh, the Institute of Cancer Research and the Instituto de Recerca Biomedica in Barcelona.

The project led by Imperial is also part of the CRUK Convergence Science Centre, a partnership between Imperial and the Institute of Cancer Research. The Centre aims to bring together engineers and physical scientists with cancer researchers to develop new tools and technologies to address unmet needs in cancer.